home.social

#biotechnology — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #biotechnology, aggregated by home.social.

  1. AstraZeneca reports tozorakimab COPD trial results

    AstraZeneca reported Phase III OBERON and TITANIA results showing tozorakimab reduced moderate and severe COPD exacerbations across broad…
    #EuropeSays #Britain #Europe #EU #AstraZeneca #Biotechnology #COPDtreatment #FDAPriorityReview #IL-33antibody #PhaseIIItrial #respiratorymedicine #tozorakimab
    europesays.com/britain/120279/

  2. BS PHARM KOREA Strengthens INHILO+ Market Development Through Distribution and Clinical Collaboration

    INHILO+ represents our approach to professional aesthetic product development through differentiated formulation concepts, clinical evaluation, and collaboration with…
    #EuropeSays #Korea #KR #Biotechnology #BSPHARMKOREA #CosmeticsandPersonalCare #MedicalPharmaceuticals #Pharmaceuticals
    europesays.com/korea/144885/

  3. Toward An Inclusive Bioeconomy Framework For Global Mountains
    --
    doi.org/10.48130/cas-0026-0003 <-- shared paper
    --
    adaptationataltitude.org/knowl <-- shared technical article
    --
    blog.icimod.org/hi-reap/from-b <-- shared technical article, “From biodiversity to livelihoods: Bhutan’s bioeconomy pathways”
    --
    “Global mountain regions have great biological, cultural, and spiritual value for people around the world, but progress in efforts to conserve montane resources has been slow. International researchers are now acting to construct a bioeconomy framework for global mountains that includes biodiversity, cultural protection, and restoration, circular economy principles, biotechnology innovation, digital integration, sustainable fair trade, and social equity and justice. Plans in five mountain regions are reviewed for initial actions to implement this framework…”
    #MountainBioeconomy #mountain #bioeconomy #economy #CircularEconomy #Biodiversity #conservation #biocultural #protection #diversity #biology #culture #circulareconomy #biotechnology #digitalintegration #sustainable #fairtrade #socialequity #socialjustice #montane #bioeconomy #global #success #metrics #montanebioeconomy #community #connection #mountain #framework #planning #policy #framing #agriculture #sustainable #foodsecurity #farmers #circularagriculture

  4. 🧬 As biodiversity faces unprecedented challenges, high-quality reference #genomes preserve invaluable biological knowledge for future generations. Together, EBP affiliates are building the genomic foundation for #discoveries in #evolution, #conservation, agriculture, #biotechnology, and beyond.

  5. Biologic medications are highly complex therapeutic mixtures derived directly from living natural sources—such as human, animal, or microorganism cells—rather than being chemically synthesized.
    #WhatIs #Pharmacology #Immunology #Biotechnology #MolecularBiology #Biomanufacturing #sflorg
    sflorg.com/2026/04/wi04212601.

  6. My article examining the personhood status of human embryos from the perspectives of their development in the womb or in a laboratory environment and their preservation through cryopreservation has just been published.

    Titled “Alabama Yüksek Mahkemesi’nin LePage & Fonde / Aysenne v. Medical Center Kararı Perspektifinden In Utero ve In Vitro Embriyonun Türk Hukukundaki Kişiliği Meselesi” (The Issue of In Utero and In Vitro Embryo Personhood in Turkish Law from the Perspective of the Alabama Supreme Court’s LePage & Fonde / Aysenne v. Medical Center Decision), the article has been published in the festschrift “Prof. Dr. Ahmet M. Kılıçoğlu Armağanı,” dedicated to our esteemed professor.

    The festschrift ceremony, held on March 27, 2026, at Atılım University Faculty of Law in Ankara, was an extremely meaningful and emotional gathering.

    I extend my sincere thanks to all the professors and everyone who contributed to making this gathering possible…

    #Technology #Biotechnology #Embryo #Law #CivilLaw #NaturalPerson

  7. Tomorrow, 16 December, #IN2PAST is promoting the meeting ‘The Crises of the Human’, aims to explore how the idea of ‘humanity’ is being unsettled, fragmented, and displaced across multiple domains.

    It will take place at Edições do Saguão (Lisbon) from 2 pm.

    Please do come along!

    ℹ️ ihc.fcsh.unl.pt/en/events/cris

    #Histodons #Humanity #Humanities #Authoritarianism #AI #ClimateChange #Pandemics #Biotechnology #Earth #History #Anthropology #Arts #Heritage

  8. 🍄🚽 Researchers at the University of #BritishColumbia created the MycoToilet, the world's first #mushroom-powered waterless toilet that uses fungal #mycelia to convert human #waste into compost without #chemicals or #electricity. The system eliminates over 90% of odors and could replace portable toilets in parks and remote areas while producing usable soil and liquid fertilizer.

    👉 popsci.com/environment/first-m

    #biotechnology #mushrooms #sustainability #composting #engineering #fungi #environment #innovation

  9. Thursday, September 4, 2025

    Ukraine destroys Russian speedboat as it attempts to land troops, Navy says, shares footage -- Behind Ukraine’s manpower crisis lies a bleak new battlefield reality for infantry -- Fears of Russian hit campaign grow as another nationalist politician is murdered in Ukraine -- No regional centers captured, 1 million dead Russian soldiers — Ukrainian official responds to Putin's threats with list of Russia's military achievements ... and more

    activitypub.writeworks.uk/2025

  10. 🔬✨ Estoy preparando todo para modificar genéticamente este moho que veis aquí. Voy a intentar darle el superpoder de destruir micotoxinas producidas por otros hongos.

    En biotecnología, los microorganismos muchas veces son el problema y la solución 👩‍🔬

    #Biotecnología #Microbiología #Fungi #Biotechnology

  11. 📣 Last chance to register for the International Biodeterioration
    and Biodegradation Symposium taking place 9 - 12 Sept. 2024 in Berlin at BAM. Get one of the few remaining spots now!

    Session topics will include #biodeterioration and #bioremediation mediated by microbes, insects, and higher organisms.

    #MIC #Biokorrosion #hazardouswaste #spillremediation #biotechnology #chemicalengineering

    The 19th triennial symposium of DECHEMA is taking place in cooperation with BAM.

    ibbs19.org/Speakers+and+Progra

  12. Merck claims late-stage study success for RSV antibody  — Novo Nordisk's Wegovy gets UK approval for lowering heart risks — J&J vets burst into biotech with $165M Third Arc series A —bit.ly/w28kSd #rsv #merck #novonordisk #uk #wegovy #funding #jnj #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  13. Abbott plans marketing push for glucose monitors beyond diabetes  — Morphic kept it simple in M&A maneuvers, staying focused on Lilly to reel in $3.2B buyout— FDA launches innovation hub to spur rare disease R&D —bit.ly/w28kSd #cgms #glucosemonitoring #abbottlabs #elililly #innovation #fda #rarediseases #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  14. 5 neuro data readouts to watch in the second half of 2024 — GSK moves to new HQ in return to central London — AbbVie led the way in paying doctors to pitch its drugs last year —bit.ly/w28kSd #clinicaltrials #neurology #gsk #london #abbvie #physicians #physicianpayments #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  15. Pfizer moves forward with once-daily version of weight loss pill after setbacks—Novo’s once-weekly insulin rejected by FDA — Could pharma’s blockbuster immunotherapies work in dogs? —bit.ly/w28kSd #pfizer #weightloss #novonordisk #type1diabetes #fda #insulin #animalhealth #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  16. 2024's layoff woes continue in Q2—Jaguar Gene’s JAG201 therapy trial for autism receives FDA approval — Most patients stop using Wegovy, Ozempic for weight loss within two years —bit.ly/w28kSd #layoffs #genetherapy #autism #wegovy #ozempic #weightloss #novonordisk #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  17. US government appeals Gilead's trial win in Truvada, Descovy patent fight—Lilly’s Mounjaro helps patients lose more weight than Novo’s Ozempic — FTC report finds PBM power has “dire consequences” —bit.ly/w28kSd #gileadsciences #patents #elililly #mounjaro #ozempic #novonordisk #ftc #pbms #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  18. Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster—GLP-1s may cut risk of 10 obesity-related cancers in diabetics —Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births —bit.ly/w28kSd #mergersandacquistions #elililly #ibd #takeda #glp1 #novonordisk #diabetes #cancer #pfizer #rsv #vaccines #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  19. Moderna receives $176 million from BARDA for mRNA influenza vaccines—J&J, Legend's Carvykti shows CAR-T can extend lives in multiple myeloma —The IRA will lower U.S. drug spending, CMS finds — but not for awhile—bit.ly/w28kSd #moderna #barda #mrna #vaccines #flu #jnj #multiplemyeloma #ira #drugspending #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  20. Gilead’s Trodelvy stumbles in late-stage trials but remains prized cancer asset—BMS axes Eisai ADC pact 3 years after paying $650M for would-be Elahere rival —Supreme Court’s Chevron Doctrine ruling could limit FDA’s regulatory authority—bit.ly/w28kSd #gileadsciences #cancer #antibodydrugconjufate #eisai #bristolmyerssquibb #supremecourt #fda #chevrondoctrine #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  21. ​​​​​​​Alumis cuts IPO size, but nets $250M for immune drug work—Philips BiPAP recall now linked to 65 deaths, 952 injuries —Where the future of Alzheimer's drugs is heading—bit.ly/w28kSd #ipos #recalls #medtech #bipap #philips #alzheimers #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  22. Supreme Court rejects controversial Purdue Pharma bankruptcy deal—FDA approves Verona Pharma's inhaled COPD therapy —FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug—bit.ly/w28kSd #supremecourt #purduepharma #bankruptcy #opioidcrisis #fda #copd #merck #cancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  23. After full approval, Sarepta lays out its next moves—Zealand Pharma brings in $1B to drive development of obesity drugs —Sanofi seeks initial offers for Its $20 billion consumer arm—bit.ly/w28kSd #sareptatherapeutics #dmd #obesity #zealandpharma #funding #consumerhealth #sanofi #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  24. 5 FDA decisions to watch in the second half of 2024—Lilly sees path for Zepbound’s label expansion with phase III sleep apnea win —BMS gets FDA approval for Krazati in colorectal cancer—bit.ly/w28kSd #fda #elililly #sleepapnea #bristolmyerssquibb #colorectalcancer #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  25. Chronic kidney disease market estimated to grow at 19.6%, driven by pipeline agents aimed at unmet needs—Lexicon Pharmaceuticals resubmits sotagliflozin NDA for type 1 diabetes —Former Stimwave CEO gets 6 years in prison for fake device scheme—bit.ly/w28kSd #chronickidneydisease #kidneydisease #medtech #type1diabetes #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  26. Biopharma dealmaking continues to rise, but M&A values hold steady—Vanda rejects buyout offers, pans 'opportunistic attempts' at securing its shares at a discount —Lilly files more lawsuits to curb sales of counterfeit Mounjaro—bit.ly/w28kSd #mergersandacquisitions #vandapharma #elililly #counterfeitdrugs #mounjaro #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  27. AstraZeneca’s Truqap flops in phase III triple-negative breast cancer trial—Merck's Keytruda snags 40th US indication, leaps ahead of GSK with broad endometrial cancer approval —Roche partners with RNA editing biotech Ascidian—bit.ly/w28kSd #astrazeneca #breastcancer #clinicaltrials #endometrialcancer #merck #fda #rna #roche #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  28. GLP-1 global obesity market to reach $111B by 2033, despite headwinds—Takeda circles leukemia rival to Novartis' Scemblix in up to $1.3B deal with Ascentage —J.P. Morgan's private financing arm closes inaugural $500M-plus biotech fund—bit.ly/w28kSd #obesity #glp1 #novonordisk #elililly #novartis #takeda #vml #funding #jpmorgan #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  29. Coherus, Junshi’s PD-1 blocker Loqtorzi aces phase III liver cancer trial—Supreme Court preserves access to abortion pill mifepristone —Pfizer gene therapy for Duchenne fails to meet goals of key trial—bit.ly/w28kSd #surpremecourt #livercancer #pfizer #dmd #genetherapy #abortionpill #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  30. The 6 largest biopharma layoffs of 2024 so far—Biosecure Act left out of Department of Defense spending bill by House Rules Committee —Pfizer, Flagship name first target for multibillion-dollar collaboration: obesity—bit.ly/w28kSd #layoffs #biosecureact #legislation #pfizer #obesity #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  31. After M&A stretch, Pfizer CEO says company needs 'breathing period' from large deals—Behind Big Pharma’s layoffs — is there an end in sight? — Lilly Alzheimer’s drug gets unanimous backing of FDA panel—bit.ly/w28kSd #pfizer #bigpharma #layoffs #alzheimers #elililly #fda #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma

  32. Moderna’s COVID-Flu combo shot beats separate vaccines in phase III study—FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date — Boehringer, Lilly face off in MASH at EASL—bit.ly/w28kSd #moderna #vaccines #flu #covid19 #alzheimers #fda #eisai #biogen #elililly #mash #easl #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma